Topical Retinoids for Pigmented Skin

May 2011 | Volume 10 | Issue 5 | Original Article | 483 | Copyright © May 2011

Aanand N. Geria MD, Christina N. Lawson MD, Rebat M. Halder MD

  1. Grimes PE. Management of Hyperpigmentation in Darker Racial Ethnic Groups. Semin Cutan Med Surg. 2009;28:77-85.
  2. Stratigos AJ, Katsambas A. Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients. Am J Clin Dermatol. 2004;5:161-168.
  3. Morelli J, Norris D. Influence of inflammatory mediators and cytokines in human melanocyte function. J Invest Dermatol. 1993;100:191S-195S.
  4. Bulengo-Ransby SM, Griffiths C, Kimbrough-Green C, Finkel LJ, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Eng J Med. 1993;328:1438-1443.
  5. Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: A double-blind, randomized, vehicle-controlled study. Cutis. 2006;77:45-50.
  6. Taylor SC. Utilizing Combination Therapy for Ethnic Skin. Cutis. 2007;80:15-20.
  7. Kurita M, Kato H, Yoshimura K. A therapeutic strategy based on histological assessment of hyperpigmented skin lesions in Asians. J Plast Reconstr Aesthet Surg. 2009;62:955-963.
  8. Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453-1457.
  9. Kimbrough-Green CK, Griffiths C, Finkel L, Hamilton TA, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994;130:727-733.
  10. Kligman A, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975;111:40-48.
  11. Grimes P, Kelly A, Torok H, Willis I. Community-Based Trial of a Triple-Combination Agent for the Treatment of Facial Melasma. Cutis. 2006;77:177-184.
  12. Cestari TF, Hassun K, Sittart A, de Lourdes Viegas M. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol. 2007;6:36-39.
  13. Chan R, Park K, Lee M, Lee ES, et al. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159:697-703.
  14. Taylor SC, Torok H, Jones T, Lowe N, et al. Efficacy and Safety of a New Triple-Combination Agent for the Treatment of Facial Melasma. Cutis. 2003;72:67-72.
  15. Nanda S, Grover C, Reddy B. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma. Dermatol Surg. 2004;30:385-388.
  16. Kligman A, Fulton J, Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol. 1969;99:469-476.
  17. Callender VD. Considerations for Treating Acne in Ethnic Skin. Cutis. 2005;76:19-23.
  18. Halder RM, Holmes Y, Bridgeman-Shah S, Kligman A. A clinicohistopathologic study of acne vulgaris in black females. J Invest Dermatol. 1996;106:888.
  19. Jacyk W. Adapalene in the treatment of African patients. J Eur Acad Dermatol Venereol. 2001;15(suppl 3):37-42.
  20. Czernielewski J, Poncet M, Mizzi F. Efficacy and Cutaneous Safety of Adapalene in Black Patients Versus White Patients With Acne Vulgaris. Cutis. 2002;70:243-248.
  21. Kawashima M, Harada S, Loesche C, Miyachi Y. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris:A randomized, multicenter, investigator-blinded, controlled study. J Dermatol Sci. 2008;49:241-248.
  22. Zhu X-J, Tu P, Zhen J, YQ D. Adapalene gel 0.1%: Effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients. Cutis. 2001;68:55-59.
  23. Saple DG, Torsekar RG, Pawanarkar V, Dhanalaskshmi UR, et al. An open study to evaluate the efficacy and safety of tazarotene gel (0.1%) in acne vulgaris. Indian J Dermatol Venereol Leprol. 2004;70:92-95.
  24. Kakita L. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris. J Am Acad Dermatol. 2000;43(2 Pt 3):51-54.
  25. Guenther L. Tazarotene combination treatments in psoriasis. J Am Acad Dermatol. 2000;43:S36-42.
  26. Angelo JS, Kar B, Thomas J. Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: A double-blind, randomized,right-left comparison study. Indian J Dermatol Venereol Leprol. 2007;73:65.
  27. Griffiths CEM, Russman A, Majmudar G, Singer R, et al. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med. 1993;329:530-535.
  28. Kligman A, Grove GH, R, Leyden J. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986;15:836-859.
  29. Griffiths CEM, Goldfarb M, Finkel L, Roulia V, et al. Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: A vehicle-controlled trial. J Am Acad Dermatol. 1994;30(1):76-84.
  30. Perry PK, Cook-Bolden FE, Rahman Z, Jones E, et al. Defining pseudofolliculitis barbae in 2001: A review of the literature and current trends. J Am Acad Dermatol. 2002;46(suppl 2):113-119.
  31. Halder RM. Pseudofolliculitis barbae and related disorders. Dermatol Clin. 1988;6:407-412.
  32. Taylor SC. Enhancing the care and treatment of skin of color, part 1: The broad scope of pigmentary disorders. Cutis. 2005;76:249-255.
  33. Abergel RP, Meeker CA, Oikarinen H, Oikarinen AI, et al. Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures. Arch Dermatol. 1985;121:632-635.
  34. Panabiere-Castaings MH. Retinoic acid in the treatment of keloids. J Dermatol Surg Oncol. 1988;14:1275-1276.
  35. Janssen de Limpens AM. The local treatment of hypertrophic scars and keloids with topical retinoic acid. Br J Dermatol. 1980;103:319-323.
  36. Foy V, Weinkauf R, Whittle E, Basketter DA. Ethnic variation in the skin irritation response . Contact Dermatitis. 2001;45:346-349.
  37. Callender VD, Preston N, Osborn C, Johnson L, et al. A Meta-Analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne. J Clin Aesthet Dermatol. 2010;3(8):15-19.